{
    "clinical_study": {
        "@rank": "23473", 
        "arm_group": [
            {
                "arm_group_label": "MKT-N2", 
                "arm_group_type": "Experimental", 
                "description": "Montelukast"
            }, 
            {
                "arm_group_label": "Singulair", 
                "arm_group_type": "Active Comparator", 
                "description": "Montelukast sodium"
            }
        ], 
        "brief_summary": {
            "textblock": "The Purpose of A center, Randomized, Open label, single dose, Placebo-controlled,\n      2-Treatment, 2-Way, 2-Period Crossover Study to Compare the Safety and the Pharmacokinetic\n      Characteristics of MKT-N2 (Montelukast) and Singulair\u00ae (montelukast sodium) tablet 10mg in\n      Healthy Male Korean Subjects"
        }, 
        "brief_title": "Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair\u00ae (Montelukast Sodium)to Treat Asthma", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Asthma and Allergic Rhinitis", 
        "condition_browse": {
            "mesh_term": [
                "Asthma", 
                "Rhinitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy Korean Male  over20, under 45 years old\n\n          -  55kg over weight, IBW +-20% range male\n\n        Exclusion Criteria:\n\n          -  Males who have gotten a clinically significant  of liver, pancreas, kidneys, nervous\n             system, respiratory system, endocrine system, blood cancer, mental illness,\n             cardiovascular, urinary tract disease, or a history corresponding\n\n          -  Males who have gotten a history of gastrointestinal disease\n\n          -  Males who have gotten a history of hypersensitivity to montelukast or reaction to\n             other drugs(aspirin, antibiotics)"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02029313", 
            "org_study_id": "PMK-M01RS1"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "MKT-N2", 
                    "Singulair"
                ], 
                "intervention_name": "Montelukast", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "MKT-N2", 
                    "Singulair"
                ], 
                "intervention_name": "Montelukast sodium", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Montelukast"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 6, 2014", 
        "location": {
            "contact": {
                "email": "shcho123@inha.ac.kr", 
                "last_name": "Sangheon Cho", 
                "phone": "82-32-890-1122"
            }, 
            "facility": {
                "address": {
                    "city": "Incheon", 
                    "country": "Korea, Republic of", 
                    "state": "Junggu"
                }, 
                "name": "Inha University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Open-label, Single-Dose, 2-Treatment, 2-Way, 2-Period Crossover Study to Compare the Safety and the Pharmacokinetic Characteristics of MKT-N2 (Montelukast) and Singulair\u00ae (Montelukast Sodium) Tablet 10mg in Healthy Male Korean Subjects", 
        "overall_contact": {
            "email": "isulala@naver.com", 
            "last_name": "Soohyun Lee", 
            "phone": "82-2-6925-4068"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Republic of Korea: Korea Food & Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of participants with Adverse event", 
            "safety_issue": "No", 
            "time_frame": "1day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02029313"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Blood evaluation variables: Cmax, AUCt (t=24 h), AUC\u221e, tmax", 
            "measure": "Pharmacokinetic profiles", 
            "safety_issue": "No", 
            "time_frame": "1day"
        }, 
        "source": "PharmaKing", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "PharmaKing", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}